Product
iNO
Aliases
Inhaled Nitric Oxide
4 clinical trials
8 indications
Indication
Pulmonary Arterial HypertensionIndication
COVID-19Indication
PneumoniaIndication
ViralIndication
Cerebrovascular DisordersIndication
StrokeIndication
Heart Transplant SurgeryIndication
Lung Transplant SurgeryClinical trial
Phase 3, Multicenter, Randomized, Double-blind, Placebo Controlled Withdrawal Study of Pulmonary Arterial Hypertension(PAH) Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric Oxide (INO)Status: Withdrawn, Estimated PCD: 2019-06-01
Clinical trial
Expanded Access: Pulsed, Inhaled Nitric Oxide (iNO) for the Treatment of Patients With Mild or Moderate Coronavirus Disease (COVID-19)Status:
Clinical trial
Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy: A Phase I Drug Pilot Research PlanStatus: Not yet recruiting, Estimated PCD: 2025-02-01
Clinical trial
Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation OutcomesStatus: Completed, Estimated PCD: 2020-10-05